Improving patient prostate cancer risk assessment: Moving from static, globally-applied to dynamic, practice-specific risk calculators

https://doi.org/10.1016/j.jbi.2015.05.001Get rights and content
Under an Elsevier user license
open archive

Highlights

  • A dynamic updating method is proposed for the prostate cancer risk tool PCPTRC.

  • The procedure is evaluated on five cohorts from the US and EU.

  • Dynamic updates of the PCPTRC are performed each year for every cohort.

  • Annual updating had little impact on discrimination.

  • Accuracy could be improved by dynamic updating.

Abstract

Clinical risk calculators are now widely available but have generally been implemented in a static and one-size-fits-all fashion. The objective of this study was to challenge these notions and show via a case study concerning risk-based screening for prostate cancer how calculators can be dynamically and locally tailored to improve on-site patient accuracy. Yearly data from five international prostate biopsy cohorts (3 in the US, 1 in Austria, 1 in England) were used to compare 6 methods for annual risk prediction: static use of the online US-developed Prostate Cancer Prevention Trial Risk Calculator (PCPTRC); recalibration of the PCPTRC; revision of the PCPTRC; building a new model each year using logistic regression, Bayesian prior-to-posterior updating, or random forests. All methods performed similarly with respect to discrimination, except for random forests, which were worse. All methods except for random forests greatly improved calibration over the static PCPTRC in all cohorts except for Austria, where the PCPTRC had the best calibration followed closely by recalibration. The case study shows that a simple annual recalibration of a general online risk tool for prostate cancer can improve its accuracy with respect to the local patient practice at hand.

Abbreviations

AUC
area under the ROC curve
BIC
Bayesian information criterion
DRE
digital rectal exam
EMR
electronic medical record
HLS
Hosmer–Lemeshow test statistic
MCMC
Markov Chain Monte Carlo
PBCG
prostate biopsy collaborative group
PCPT
prostate cancer prevention trial
PCPTRC
prostate cancer prevention trial risk calculator
PSA
prostate specific antigen
ROC
receiver operating characteristic
SABOR
San Antonio center of biomarkers of risk for prostate cancer

Keywords

Prediction
Discrimination
Calibration
Prostate cancer
Logistic regression
Revision

Cited by (0)